Chikujee Therapeutics, was founded by biotechnology entrepreneurs with successful track record with the aim to be an innovative life science company to create, manufacture and market innovative solutions of high quality for unmet medical needs. Our products and services help to prevent, diagnose and treat cancer, thus enhancing people's health and quality of life. We do this in a responsible and ethical manner and with a commitment to sustainable development respecting the needs of the individual, the society and the environment.

we are developing an entirely new class of personalized medicines that provide a cancer cell-specific detection and/or a tumor marker-specific targeted therapeutic and cancer monitoring capabilities to healthcare professional. The diagnostics, therapeutic and monitoring capabilities are non-invasive and extremely patient-friendly.

Chikujee’s proprietary Aayush (Aayush™) platform creates a new paradigm in multifunctional therapeutics development, enabling completely new detection, targeted therapeutic and clinical monitoring applications with significantly improved efficacy and safety profiles.

At Chikujee Therapeutics, our passion is the creation of meaningful and innovative life science technologies that show high growth potential and are well-positioned to make a difference in the marketplace. We work collaboratively with market leaders to focus on creating value from our technologies that have the potential for delivering multiple product opportunities.

We believe there is significant value in product engines “new biological and technologic platforms capable of creating products for detection, treatment and monitoring of cancer, which have the potential for broad applications, market leadership and extraordinary value creation. Initial focus of Chikujee Therapeutics will be to develop product engines for early detection and targeted drug delivery for cancer. The long term goal is to develop integrated patient-friendly personalized products that enhance quality of life.